Thyroid Hormone Synthesis Inhibitor [EPC]

Thyroid Hormone Synthesis Inhibitor [EPC] was reported 9751 times

Drugs of the Thyroid Hormone Synthesis Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTITHYROID ARTHRITIS SYNDROME 26 0.9630
1 THYROTOXIC MYOPATHY 11 0.8462
2 CONGENITAL CLAVICULAR AGENESIS 7 0.5833
3 NEONATAL THYROTOXICOSIS 12 0.5000
4 GOITRE CONGENITAL 14 0.3889
5 THYROTOXIC CARDIOMYOPATHY 8 0.3636
6 CONGENITAL HYPERTHYROIDISM 7 0.2593
7 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 20 0.2500
8 THYROTOXIC PERIODIC PARALYSIS 31 0.2123
9 DEAFNESS PERMANENT 40 0.2041
10 TOXIC GOITRE 10 0.1639
11 THYROTOXIC CRISIS 177 0.1555
12 CHOANAL ATRESIA 17 0.1417
13 APLASIA CUTIS CONGENITA 19 0.1329
14 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 8 0.1159
15 ENDOCRINE OPHTHALMOPATHY 99 0.1141
16 TOXIC NODULAR GOITRE 13 0.0985
17 ANTI-THYROID ANTIBODY INCREASED 10 0.0794
18 CAFE AU LAIT SPOTS 7 0.0700
19 CONGENITAL HYPOTHYROIDISM 16 0.0620
20 POST PROCEDURAL HYPOTHYROIDISM 12 0.0566
21 IMMATURE RESPIRATORY SYSTEM 7 0.0446
22 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 109 0.0441
23 HYPERTHYROIDISM 523 0.0361
24 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 26 0.0355
25 TRI-IODOTHYRONINE INCREASED 14 0.0351
26 BASEDOW'S DISEASE 16 0.0340
27 INSULIN AUTOIMMUNE SYNDROME 12 0.0336
28 GINGIVITIS ULCERATIVE 7 0.0326
29 THYROXINE FREE INCREASED 20 0.0312
30 EXOMPHALOS 16 0.0298
31 KIDNEY DUPLEX 7 0.0292
32 ECTHYMA 10 0.0249
33 EOSINOPHILIC PLEURAL EFFUSION 7 0.0235
34 DEAFNESS NEUROSENSORY 68 0.0207
35 CHOLURIA 7 0.0205
36 GOITRE 84 0.0205
37 EXOPHTHALMOS 43 0.0200
38 ANAL STENOSIS 9 0.0169
39 TYPE V HYPERLIPIDAEMIA 8 0.0165
40 LIP EROSION 12 0.0164
41 AGRANULOCYTOSIS 303 0.0163
42 THYROXINE INCREASED 11 0.0156
43 ISCHAEMIC HEPATITIS 21 0.0153
44 EAR MALFORMATION 7 0.0151
45 OBSTRUCTIVE PANCREATITIS 11 0.0144
46 MOTOR DEVELOPMENTAL DELAY 8 0.0138
47 SKULL MALFORMATION 8 0.0124
48 PHIMOSIS 9 0.0122
49 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 13 0.0116
50 DYSMORPHISM 27 0.0115
51 SYNDACTYLY 9 0.0108
52 GASTROINTESTINAL MUCOSAL DISORDER 7 0.0107
53 JAUNDICE CHOLESTATIC 37 0.0105
54 PYELOCALIECTASIS 10 0.0104
55 CENTRAL SEROUS CHORIORETINOPATHY 7 0.0102
56 PULMONARY VALVE STENOSIS 8 0.0100
57 POLYHYDRAMNIOS 10 0.0098
58 THYROIDITIS 29 0.0096
59 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
60 CONSCIOUSNESS FLUCTUATING 10 0.0096
61 TWIN PREGNANCY 8 0.0095
62 BLOOD THYROID STIMULATING HORMONE DECREASED 43 0.0095
63 PULSELESS ELECTRICAL ACTIVITY 39 0.0093
64 CRYPTORCHISM 10 0.0089
65 SKIN SENSITISATION 9 0.0087
66 CHOLESTATIC LIVER INJURY 19 0.0085
67 FOETAL DISORDER 7 0.0084
68 LEUKOCYTOCLASTIC VASCULITIS 13 0.0080
69 THYROID MASS 29 0.0076
70 THYROIDECTOMY 13 0.0075
71 PHYSICAL DISABILITY 33 0.0075
72 CARDIOGENIC SHOCK 106 0.0074
73 KLEBSIELLA SEPSIS 8 0.0071
74 PAROTITIS 8 0.0069
75 FOETAL DISTRESS SYNDROME 14 0.0066
76 MEAN CELL VOLUME DECREASED 10 0.0065
77 HYPOTHYROIDISM 205 0.0064
78 POLYARTHRITIS 31 0.0059
79 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
80 VENTRICULAR DYSFUNCTION 15 0.0058
81 THYROID FUNCTION TEST ABNORMAL 24 0.0058
82 CONCOMITANT DISEASE AGGRAVATED 35 0.0057
83 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 34 0.0056
84 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
85 PULMONARY ALVEOLAR HAEMORRHAGE 31 0.0055
86 ESSENTIAL HYPERTENSION 10 0.0055
87 APGAR SCORE LOW 7 0.0054
88 DACRYOSTENOSIS ACQUIRED 7 0.0054
89 LIVER TRANSPLANT 19 0.0052
90 CUTANEOUS VASCULITIS 19 0.0052
91 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43 0.0049
92 AUDITORY DISORDER 7 0.0049
93 THYROID DISORDER 76 0.0049
94 ACUTE HEPATIC FAILURE 67 0.0049
95 SYSTEMIC INFECTION 8 0.0048
96 HYPERSENSITIVITY VASCULITIS 12 0.0046
97 LOW BIRTH WEIGHT BABY 36 0.0045
98 KOUNIS SYNDROME 10 0.0044
99 MATERNAL DRUGS AFFECTING FOETUS 33 0.0043
100 CRYPTOCOCCOSIS 7 0.0043
101 BILIRUBIN CONJUGATED INCREASED 10 0.0043
102 ESCHERICHIA BACTERAEMIA 10 0.0042
103 POSTURE ABNORMAL 13 0.0040
104 CHRONIC GASTRITIS 9 0.0040
105 HEPATITIS CHOLESTATIC 24 0.0040
106 SYSTEMIC CANDIDA 10 0.0040
107 HAEMANGIOMA 9 0.0039
108 SMALL FOR DATES BABY 19 0.0038
109 IMPAIRED QUALITY OF LIFE 55 0.0038
110 HAEMODYNAMIC INSTABILITY 29 0.0038
111 VASCULITIS 44 0.0038
112 PHARYNGEAL ERYTHEMA 8 0.0038
113 LUPUS NEPHRITIS 7 0.0037
114 SINUS BRADYCARDIA 36 0.0037
115 HEPATIC NECROSIS 14 0.0037
116 AUTOIMMUNE THYROIDITIS 14 0.0037
117 EAR DISCOMFORT 38 0.0037
118 DRUG-INDUCED LIVER INJURY 116 0.0037
119 MIXED LIVER INJURY 11 0.0037
120 SPEECH DISORDER DEVELOPMENTAL 10 0.0035
121 PREMATURE BABY 104 0.0035
122 TONSILLITIS 18 0.0034
123 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 8 0.0034
124 PREMATURE DELIVERY 53 0.0033
125 VENTRICULAR SEPTAL DEFECT 19 0.0033
126 HYPERBILIRUBINAEMIA 34 0.0033
127 VENTRICULAR ARRHYTHMIA 12 0.0033
128 INFUSION SITE BRUISING 7 0.0032
129 DIASTOLIC DYSFUNCTION 10 0.0032
130 HENOCH-SCHONLEIN PURPURA 7 0.0032
131 HYPERPARATHYROIDISM SECONDARY 8 0.0032
132 OTITIS MEDIA 10 0.0030
133 PHARYNGOLARYNGEAL PAIN 16 0.0030
134 HEPATIC ENCEPHALOPATHY 28 0.0030
135 EAR CONGESTION 8 0.0029
136 CLONUS 8 0.0029
137 APLASTIC ANAEMIA 15 0.0029
138 ORAL DISORDER 21 0.0029
139 GLOMERULONEPHRITIS 7 0.0029
140 NEONATAL RESPIRATORY DISTRESS SYNDROME 10 0.0028
141 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
142 HYPERTONIA 16 0.0028
143 PRODUCT USE COMPLAINT 44 0.0028
144 LABYRINTHITIS 7 0.0028
145 OCULAR ICTERUS 12 0.0028
146 TINNITUS 127 0.0028
147 MONOCYTE COUNT INCREASED 10 0.0028
148 THERAPEUTIC REACTION TIME DECREASED 8 0.0027
149 INFUSION SITE SWELLING 17 0.0027
150 VENTRICULAR FIBRILLATION 30 0.0027
151 HEPATITIS FULMINANT 8 0.0027
152 ACUTE PULMONARY OEDEMA 15 0.0027
153 IRON DEFICIENCY 12 0.0027
154 ECONOMIC PROBLEM 40 0.0026
155 BLOOD THYROID STIMULATING HORMONE INCREASED 24 0.0026
156 HEART DISEASE CONGENITAL 9 0.0025
157 INTESTINAL ISCHAEMIA 14 0.0025
158 MULTIPLE ORGAN DYSFUNCTION SYNDROME 72 0.0025
159 INFUSION SITE PRURITUS 8 0.0025
160 FOETAL EXPOSURE DURING PREGNANCY 206 0.0025
161 LIVE BIRTH 21 0.0025
162 CHOLESTASIS 48 0.0025
163 PURPURA 22 0.0025
164 ONYCHOCLASIS 17 0.0025
165 FOETAL GROWTH RESTRICTION 15 0.0025
166 LYMPHOCYTE COUNT INCREASED 8 0.0024
167 EYELID MARGIN CRUSTING 7 0.0024
168 DIPLOPIA 62 0.0024
169 POTENTIATING DRUG INTERACTION 8 0.0024
170 NEPHROGENIC ANAEMIA 11 0.0024
171 YELLOW SKIN 11 0.0023
172 BRAIN HERNIATION 7 0.0023
173 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
174 CAESAREAN SECTION 27 0.0023
175 KIDNEY TRANSPLANT REJECTION 11 0.0023
176 CIRCULATORY COLLAPSE 39 0.0023
177 TRICUSPID VALVE INCOMPETENCE 18 0.0023
178 BLOOD CREATININE DECREASED 7 0.0022
179 EXPOSURE DURING PREGNANCY 137 0.0022
180 HEPATOTOXICITY 49 0.0022
181 CONGENITAL ANOMALY 17 0.0022
182 CARDIOMEGALY 27 0.0022
183 ANTINUCLEAR ANTIBODY POSITIVE 7 0.0022
184 HEPATITIS ACUTE 14 0.0022
185 HYPERACUSIS 8 0.0021
186 ATRIAL FLUTTER 17 0.0021
187 VENTRICULAR TACHYCARDIA 35 0.0021
188 GRANULOCYTOPENIA 12 0.0021
189 CARDIAC TAMPONADE 10 0.0021
190 CARDIAC FAILURE ACUTE 14 0.0021
191 LUPUS-LIKE SYNDROME 19 0.0021
192 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
193 EPIGASTRIC DISCOMFORT 8 0.0020
194 STEVENS-JOHNSON SYNDROME 45 0.0020
195 RHINITIS ALLERGIC 9 0.0020
196 CARDIAC ARREST 165 0.0020
197 TRIGEMINAL NEURALGIA 8 0.0020
198 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
199 SINUS TACHYCARDIA 28 0.0020
200 LIVER INJURY 48 0.0020
201 INFUSION SITE PAIN 25 0.0019
202 TEMPERATURE INTOLERANCE 20 0.0019
203 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
204 PULMONARY HAEMORRHAGE 15 0.0019
205 ATRIAL SEPTAL DEFECT 16 0.0019
206 JAUNDICE 51 0.0019
207 AUTOIMMUNE HEPATITIS 13 0.0019
208 HYPERCALCAEMIA 23 0.0019
209 BODY TEMPERATURE DECREASED 18 0.0018
210 TREATMENT NONCOMPLIANCE 100 0.0018
211 TYPE 1 DIABETES MELLITUS 11 0.0018
212 HYPERVOLAEMIA 9 0.0018
213 NEPHROPATHY 17 0.0018
214 ACUTE RESPIRATORY FAILURE 35 0.0018
215 ORGANISING PNEUMONIA 9 0.0018
216 INGUINAL HERNIA 11 0.0018
217 BRAIN INJURY 18 0.0018
218 ERYSIPELAS 9 0.0018
219 MITRAL VALVE INCOMPETENCE 20 0.0018
220 BLOOD ALBUMIN DECREASED 14 0.0018
221 HEPATITIS 45 0.0018
222 IMMUNE THROMBOCYTOPENIA 8 0.0017
223 VITAMIN D DEFICIENCY 17 0.0017
224 ISCHAEMIA 8 0.0017
225 IRON DEFICIENCY ANAEMIA 16 0.0017
226 MYASTHENIA GRAVIS 14 0.0017
227 ADRENAL INSUFFICIENCY 21 0.0017
228 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
229 HYPERTHERMIA 13 0.0017
230 PRE-ECLAMPSIA 8 0.0017
231 ODYNOPHAGIA 10 0.0017
232 SYMPTOM RECURRENCE 10 0.0017
233 BRAIN OEDEMA 21 0.0017
234 INFUSION SITE ERYTHEMA 14 0.0017
235 GUILLAIN-BARRE SYNDROME 8 0.0017
236 AORTIC VALVE INCOMPETENCE 7 0.0016
237 RENAL TUBULAR NECROSIS 16 0.0016
238 ABNORMAL LOSS OF WEIGHT 11 0.0016
239 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
240 PANCYTOPENIA 90 0.0016
241 ECCHYMOSIS 11 0.0016
242 REBOUND EFFECT 18 0.0016
243 HEPATIC FAILURE 48 0.0016
244 END STAGE RENAL DISEASE 29 0.0016
245 LUNG INFILTRATION 14 0.0016
246 CARDIAC FAILURE 127 0.0016
247 HYPERTRANSAMINASAEMIA 11 0.0016
248 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
249 HYPERKALAEMIA 55 0.0016
250 ENTEROCOLITIS 9 0.0016
251 PROCTALGIA 10 0.0016
252 ATRIAL FIBRILLATION 151 0.0015
253 EAR PAIN 30 0.0015
254 NEUTROPENIC SEPSIS 11 0.0015
255 SEPTIC SHOCK 67 0.0015
256 TASTE DISORDER 31 0.0015
257 DISABILITY 30 0.0015
258 CONJUNCTIVITIS 28 0.0015
259 INTERNATIONAL NORMALISED RATIO INCREASED 43 0.0015
260 PROTHROMBIN TIME PROLONGED 9 0.0015
261 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
262 FOOD POISONING 8 0.0015
263 LIVER FUNCTION TEST INCREASED 32 0.0015
264 BRADYCARDIA 79 0.0015
265 OVERWEIGHT 8 0.0015
266 UPPER GASTROINTESTINAL HAEMORRHAGE 25 0.0015
267 NORMAL NEWBORN 8 0.0015
268 ENCEPHALOPATHY 36 0.0015
269 CARDIOTOXICITY 13 0.0015
270 HAIR DISORDER 12 0.0015
271 SPLENOMEGALY 17 0.0014
272 THERAPY NON-RESPONDER 65 0.0014
273 BLOOD BILIRUBIN INCREASED 39 0.0014
274 DRUG EXPOSURE DURING PREGNANCY 49 0.0014
275 LEUKOPENIA 72 0.0014
276 SWELLING OF EYELID 9 0.0014
277 HYPERLIPIDAEMIA 17 0.0014
278 PERIORBITAL SWELLING 8 0.0014
279 PREMATURE LABOUR 8 0.0014
280 SEASONAL ALLERGY 20 0.0014
281 PULMONARY MASS 21 0.0014
282 TORSADE DE POINTES 11 0.0014
283 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
284 PSEUDOMONAS INFECTION 12 0.0014
285 EXERCISE TOLERANCE DECREASED 8 0.0014
286 MYOPATHY 12 0.0014
287 CARDIAC MURMUR 12 0.0014
288 GENERALISED OEDEMA 17 0.0014
289 SPUTUM DISCOLOURED 13 0.0014
290 MATERNAL EXPOSURE DURING PREGNANCY 122 0.0014
291 NEUTROPHIL COUNT INCREASED 14 0.0014
292 HAEMATOCRIT DECREASED 27 0.0014
293 CACHEXIA 7 0.0014
294 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
295 SHOCK 31 0.0013
296 ATELECTASIS 13 0.0013
297 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
298 AUTOIMMUNE DISORDER 13 0.0013
299 CATATONIA 7 0.0013
300 RESPIRATORY FAILURE 97 0.0013
301 DISCOMFORT 81 0.0013
302 HAEMOPTYSIS 37 0.0013
303 OSTEOPENIA 20 0.0013
304 LIGAMENT SPRAIN 13 0.0013
305 BLOOD UREA INCREASED 22 0.0013
306 PNEUMONIA BACTERIAL 12 0.0013
307 RESPIRATION ABNORMAL 9 0.0013
308 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 71 0.0013
309 PANCREATITIS ACUTE 29 0.0013
310 PULMONARY CONGESTION 17 0.0013
311 HEPATIC STEATOSIS 24 0.0013
312 HYDROCEPHALUS 7 0.0013
313 HYPOKALAEMIA 59 0.0013
314 PULMONARY TOXICITY 9 0.0013
315 HAIR TEXTURE ABNORMAL 17 0.0013
316 CHOKING SENSATION 7 0.0013
317 FOOT DEFORMITY 14 0.0013
318 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
319 ELECTROCARDIOGRAM QT PROLONGED 45 0.0012
320 OCULAR DISCOMFORT 14 0.0012
321 RHABDOMYOLYSIS 52 0.0012
322 WEIGHT FLUCTUATION 13 0.0012
323 RESPIRATORY DISTRESS 34 0.0012
324 MAJOR DEPRESSION 9 0.0012
325 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
326 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
327 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
328 PLEURAL EFFUSION 74 0.0012
329 CHRONIC KIDNEY DISEASE 92 0.0012
330 PHARYNGITIS 15 0.0012
331 ACUTE CORONARY SYNDROME 10 0.0012
332 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
333 COAGULOPATHY 20 0.0012
334 NEUTROPENIA 163 0.0012
335 EOSINOPHILIA 21 0.0012
336 DISEASE RECURRENCE 57 0.0012
337 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
338 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
339 TACHYCARDIA 105 0.0012
340 GINGIVAL BLEEDING 16 0.0012
341 PHOTOPHOBIA 22 0.0012
342 PERICARDIAL EFFUSION 27 0.0012
343 UNRESPONSIVE TO STIMULI 30 0.0012
344 ANURIA 10 0.0012
345 EYE PAIN 65 0.0012
346 CARDIOMYOPATHY 17 0.0011
347 RIGHT VENTRICULAR FAILURE 8 0.0011
348 OCULAR HYPERAEMIA 54 0.0011
349 BODY HEIGHT DECREASED 12 0.0011
350 PNEUMONIA ASPIRATION 28 0.0011
351 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
352 FACIAL PAIN 10 0.0011
353 MADAROSIS 13 0.0011
354 QUALITY OF LIFE DECREASED 15 0.0011
355 PALPITATIONS 130 0.0011
356 VISUAL FIELD DEFECT 8 0.0011
357 DECUBITUS ULCER 9 0.0011
358 PULMONARY HYPERTENSION 23 0.0011
359 HYPOTONIA 11 0.0011
360 FEBRILE NEUTROPENIA 73 0.0011
361 FAECES SOFT 8 0.0011
362 FOREIGN BODY SENSATION IN EYES 7 0.0011
363 BLOOD IRON DECREASED 13 0.0011
364 EXOSTOSIS 10 0.0011
365 ESCHERICHIA INFECTION 9 0.0011
366 GASTROINTESTINAL HAEMORRHAGE 90 0.0011
367 NOCTURIA 13 0.0011
368 RESPIRATORY TRACT CONGESTION 17 0.0011
369 HYPOACUSIS 46 0.0011
370 ORAL CANDIDIASIS 14 0.0011
371 LYMPHOPENIA 15 0.0011
372 BLOOD URINE PRESENT 20 0.0011
373 VITAMIN D DECREASED 9 0.0011
374 MUSCLE SPASMS 193 0.0011
375 AORTIC ANEURYSM 8 0.0011
376 HYPOXIA 37 0.0010
377 BLOOD POTASSIUM INCREASED 17 0.0010
378 HAIR COLOUR CHANGES 13 0.0010
379 MENTAL STATUS CHANGES 29 0.0010
380 BREAST MASS 7 0.0010
381 PRODUCT PHYSICAL ISSUE 21 0.0010
382 ACUTE KIDNEY INJURY 158 0.0010
383 EJECTION FRACTION DECREASED 16 0.0010
384 DRUG TOXICITY 14 0.0010
385 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
386 AKATHISIA 14 0.0010
387 SPINAL OSTEOARTHRITIS 9 0.0010
388 TUMOUR LYSIS SYNDROME 9 0.0010
389 EYE SWELLING 38 0.0010
390 GASTROINTESTINAL INFLAMMATION 8 0.0010
391 PERIPHERAL COLDNESS 14 0.0010
392 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
393 ASPARTATE AMINOTRANSFERASE INCREASED 54 0.0010
394 DRUG ERUPTION 18 0.0010
395 JOINT EFFUSION 7 0.0010
396 PRODUCT DISPENSING ERROR 22 0.0010
397 BLOOD SODIUM DECREASED 19 0.0010
398 CHOLECYSTITIS 12 0.0010
399 CARDIO-RESPIRATORY ARREST 42 0.0010
400 SCIATICA 16 0.0010
401 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
402 CARDIAC FAILURE CONGESTIVE 80 0.0010
403 BEDRIDDEN 13 0.0010
404 HAND FRACTURE 7 0.0010
405 HEPATOCELLULAR INJURY 14 0.0010
406 POLYURIA 8 0.0010
407 ABNORMAL FAECES 8 0.0010
408 EMOTIONAL DISTRESS 118 0.0010
409 LOCAL SWELLING 17 0.0010
410 OROPHARYNGEAL PAIN 90 0.0010
411 FLUID OVERLOAD 14 0.0010
412 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
413 FLANK PAIN 9 0.0010
414 LACERATION 9 0.0010
415 PRODUCT USE IN UNAPPROVED INDICATION 237 0.0010
416 DYSPNOEA EXERTIONAL 36 0.0010
417 MOUTH HAEMORRHAGE 7 0.0010
418 ASCITES 28 0.0010
419 HYPOCALCAEMIA 18 0.0010
420 SENSATION OF FOREIGN BODY 8 0.0009
421 EPISTAXIS 71 0.0009
422 MUSCLE ATROPHY 12 0.0009
423 CEREBRAL DISORDER 7 0.0009
424 HEMIPARESIS 16 0.0009
425 BONE MARROW FAILURE 19 0.0009
426 DRUG RESISTANCE 24 0.0009
427 BLOOD PRESSURE DECREASED 62 0.0009
428 IRRITABLE BOWEL SYNDROME 20 0.0009
429 PSYCHOLOGICAL TRAUMA 8 0.0009
430 HIATUS HERNIA 12 0.0009
431 PLATELET COUNT INCREASED 12 0.0009
432 LIMB INJURY 25 0.0009
433 HYPOTENSION 184 0.0009
434 HEPATOMEGALY 9 0.0009
435 BLOOD CALCIUM INCREASED 8 0.0009
436 APHTHOUS ULCER 7 0.0009
437 OSTEOPOROSIS 37 0.0009
438 TRANSAMINASES INCREASED 20 0.0009
439 HEART RATE INCREASED 89 0.0009
440 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
441 SWOLLEN TONGUE 28 0.0009
442 BRAIN FOG 14 0.0009
443 GOUT 16 0.0009
444 MYOSITIS 8 0.0009
445 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
446 NEUTROPHIL COUNT DECREASED 36 0.0009
447 FURUNCLE 7 0.0009
448 PRODUCT USE ISSUE 166 0.0009
449 PNEUMOTHORAX 14 0.0009
450 DEAFNESS 23 0.0009
451 GINGIVAL PAIN 7 0.0009
452 HYPERGLYCAEMIA 32 0.0009
453 DERMATITIS CONTACT 10 0.0009
454 RENAL IMPAIRMENT 73 0.0009
455 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
456 MUSCLE DISORDER 7 0.0009
457 HEPATIC CYTOLYSIS 11 0.0009
458 LACRIMATION INCREASED 26 0.0009
459 PRODUCTIVE COUGH 41 0.0009
460 RENAL FAILURE 114 0.0009
461 SINUS DISORDER 17 0.0009
462 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
463 DEFORMITY 8 0.0009
464 DIARRHOEA HAEMORRHAGIC 8 0.0009
465 ALOPECIA 168 0.0009
466 ANOREXIA 11 0.0009
467 SCRATCH 9 0.0009
468 CONTUSION 82 0.0009
469 EYE DISORDER 28 0.0009
470 INSURANCE ISSUE 13 0.0008
471 OSTEOARTHRITIS 36 0.0008
472 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
473 GASTROOESOPHAGEAL REFLUX DISEASE 68 0.0008
474 DEVICE RELATED INFECTION 13 0.0008
475 ANXIETY 240 0.0008
476 AGEUSIA 21 0.0008
477 ANKLE FRACTURE 13 0.0008
478 POLLAKIURIA 35 0.0008
479 SLEEP APNOEA SYNDROME 16 0.0008
480 PARALYSIS 12 0.0008
481 WEIGHT DECREASED 234 0.0008
482 DYSPHONIA 49 0.0008
483 MYALGIA 142 0.0008
484 HYPONATRAEMIA 47 0.0008
485 SARS-COV-2 TEST POSITIVE 11 0.0008
486 PHARYNGITIS STREPTOCOCCAL 9 0.0008
487 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
488 WHITE BLOOD CELL COUNT DECREASED 90 0.0008
489 CANDIDA INFECTION 14 0.0008
490 SKIN LACERATION 9 0.0008
491 BLOOD CREATININE INCREASED 54 0.0008
492 CYANOSIS 13 0.0008
493 HYPOKINESIA 12 0.0008
494 PULMONARY OEDEMA 37 0.0008
495 OESOPHAGITIS 9 0.0008
496 CONDITION AGGRAVATED 250 0.0008
497 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
498 GASTROINTESTINAL PAIN 9 0.0008
499 SCAR 14 0.0008
500 THROMBOCYTOPENIA 91 0.0008
501 THERAPY CHANGE 8 0.0008
502 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
503 METABOLIC ACIDOSIS 26 0.0008
504 OEDEMA PERIPHERAL 99 0.0008
505 BLOOD MAGNESIUM DECREASED 7 0.0008
506 HOSPICE CARE 8 0.0008
507 TACHYPNOEA 11 0.0008
508 GAIT INABILITY 27 0.0008
509 HALLUCINATION, VISUAL 17 0.0008
510 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42 0.0008
511 BLOOD PRESSURE INCREASED 123 0.0008
512 HYPOGLYCAEMIA 39 0.0008
513 ANAEMIA 153 0.0008
514 TYPE 2 DIABETES MELLITUS 27 0.0008
515 OVARIAN CYST 8 0.0008
516 HEART RATE DECREASED 28 0.0008
517 HEART RATE IRREGULAR 18 0.0008
518 LYMPHADENOPATHY 28 0.0008
519 APHONIA 11 0.0008
520 DYSSTASIA 23 0.0008
521 SUBARACHNOID HAEMORRHAGE 8 0.0008
522 FAECES DISCOLOURED 17 0.0008
523 INJURY 55 0.0008
524 ARRHYTHMIA 37 0.0008
525 PRODUCT PRESCRIBING ISSUE 17 0.0008
526 ACUTE MYOCARDIAL INFARCTION 23 0.0008
527 INITIAL INSOMNIA 8 0.0008
528 ROTATOR CUFF SYNDROME 10 0.0008
529 DEVELOPMENTAL DELAY 7 0.0008
530 NIGHT SWEATS 25 0.0008
531 VENTRICULAR EXTRASYSTOLES 8 0.0008
532 EYE DISCHARGE 8 0.0008
533 NECK PAIN 43 0.0008
534 ABASIA 19 0.0008
535 FLUID RETENTION 39 0.0008
536 BLOOD POTASSIUM DECREASED 23 0.0008
537 APHASIA 23 0.0008
538 ANOSMIA 11 0.0008
539 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
540 RENAL FAILURE ACUTE 32 0.0008
541 CHROMATURIA 17 0.0008
542 MULTI-ORGAN FAILURE 13 0.0008
543 WRIST FRACTURE 9 0.0008
544 HEPATIC FUNCTION ABNORMAL 28 0.0007
545 MUSCULAR WEAKNESS 85 0.0007
546 THYROID CANCER 9 0.0007
547 LIMB DISCOMFORT 23 0.0007
548 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
549 AMENORRHOEA 13 0.0007
550 PRURITUS GENERALISED 16 0.0007
551 FOOT FRACTURE 14 0.0007
552 NO THERAPEUTIC RESPONSE 9 0.0007
553 ARTHRITIS 58 0.0007
554 THROAT IRRITATION 33 0.0007
555 GALLBLADDER DISORDER 13 0.0007
556 MELAENA 16 0.0007
557 CEREBRAL HAEMORRHAGE 26 0.0007
558 BLOOD COUNT ABNORMAL 11 0.0007
559 DRUG INTERACTION 115 0.0007
560 HERNIA 14 0.0007
561 ANHEDONIA 19 0.0007
562 FLATULENCE 41 0.0007
563 GASTRITIS 19 0.0007
564 DRY EYE 36 0.0007
565 OSTEOMYELITIS 13 0.0007
566 MALNUTRITION 8 0.0007
567 NASAL CONGESTION 42 0.0007
568 COELIAC DISEASE 7 0.0007
569 BONE DISORDER 13 0.0007
570 BURNING SENSATION 50 0.0007
571 ABDOMINAL PAIN LOWER 18 0.0007
572 BLOOD TEST ABNORMAL 10 0.0007
573 MUSCULOSKELETAL CHEST PAIN 11 0.0007
574 SKIN REACTION 10 0.0007
575 URINARY INCONTINENCE 21 0.0007
576 EYE INFECTION 8 0.0007
577 STATUS EPILEPTICUS 8 0.0007
578 BLOOD PRESSURE FLUCTUATION 17 0.0007
579 PAIN IN JAW 20 0.0007
580 HEPATIC ENZYME INCREASED 48 0.0007
581 IMPAIRED DRIVING ABILITY 8 0.0007
582 SCAB 8 0.0007
583 ABDOMINAL DISTENSION 73 0.0007
584 SUBDURAL HAEMATOMA 10 0.0007
585 DYSPHAGIA 66 0.0007
586 EMPHYSEMA 7 0.0007
587 DIZZINESS 346 0.0007
588 HEPATIC CIRRHOSIS 13 0.0007
589 WHEEZING 41 0.0007
590 HYPERHIDROSIS 89 0.0007
591 NERVOUSNESS 36 0.0007
592 EYELID PTOSIS 7 0.0007
593 LIVER FUNCTION TEST ABNORMAL 20 0.0007
594 ASTHENIA 258 0.0007
595 OFF LABEL USE 600 0.0007
596 GASTRIC ULCER 13 0.0007
597 PROTEINURIA 13 0.0007
598 SINUSITIS 70 0.0007
599 IMMUNE SYSTEM DISORDER 9 0.0007
600 FEELING JITTERY 13 0.0007
601 PYREXIA 236 0.0007
602 SEPSIS 76 0.0007
603 TREMOR 113 0.0007
604 RIB FRACTURE 14 0.0007
605 DEMENTIA 19 0.0007
606 DYSURIA 25 0.0007
607 HERPES ZOSTER 39 0.0007
608 POST PROCEDURAL COMPLICATION 13 0.0007
609 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
610 BACK DISORDER 11 0.0007
611 BACTERAEMIA 8 0.0007
612 RENAL INJURY 20 0.0007
613 RASH ERYTHEMATOUS 32 0.0007
614 POLYNEUROPATHY 8 0.0007
615 STAPHYLOCOCCAL INFECTION 22 0.0007
616 DYSKINESIA 27 0.0007
617 HYPOAESTHESIA ORAL 10 0.0007
618 FULL BLOOD COUNT ABNORMAL 7 0.0007
619 PRODUCT SUBSTITUTION ISSUE 38 0.0007
620 NEURALGIA 16 0.0007
621 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
622 ANGIOEDEMA 29 0.0007
623 CHEST DISCOMFORT 67 0.0007
624 INSOMNIA 174 0.0007
625 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
626 FATIGUE 508 0.0007
627 BRONCHITIS 48 0.0006
628 BALANCE DISORDER 56 0.0006
629 MASS 9 0.0006
630 LETHARGY 37 0.0006
631 PERIPHERAL SWELLING 99 0.0006
632 HAEMATURIA 22 0.0006
633 BLISTER 36 0.0006
634 ASPIRATION 7 0.0006
635 FEELING HOT 39 0.0006
636 DELIRIUM 22 0.0006
637 FUNGAL INFECTION 21 0.0006
638 TOOTH DISORDER 14 0.0006
639 ULCER 10 0.0006
640 INFLUENZA 70 0.0006
641 INTRAOCULAR PRESSURE INCREASED 8 0.0006
642 COUGH 175 0.0006
643 PARAESTHESIA ORAL 9 0.0006
644 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
645 LYMPHOCYTE COUNT DECREASED 11 0.0006
646 URINARY TRACT INFECTION 106 0.0006
647 HEAD DISCOMFORT 11 0.0006
648 ILLNESS 64 0.0006
649 CHEST PAIN 115 0.0006
650 PRURITUS 238 0.0006
651 THERAPY INTERRUPTED 44 0.0006
652 HAEMORRHOIDS 12 0.0006
653 SWELLING FACE 40 0.0006
654 CHILLS 72 0.0006
655 SKIN FISSURES 12 0.0006
656 HAEMOGLOBIN DECREASED 63 0.0006
657 ARTHRALGIA 255 0.0006
658 BACK PAIN 142 0.0006
659 CHOLELITHIASIS 20 0.0006
660 LIVER DISORDER 27 0.0006
661 EYE IRRITATION 35 0.0006
662 INFLUENZA LIKE ILLNESS 50 0.0006
663 DIARRHOEA 390 0.0006
664 PARAESTHESIA 95 0.0006
665 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
666 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
667 ABDOMINAL PAIN 140 0.0006
668 GAIT DISTURBANCE 115 0.0006
669 MIGRAINE 57 0.0006
670 HEADACHE 373 0.0006
671 DECREASED APPETITE 138 0.0006
672 PRODUCT ADMINISTRATION ERROR 12 0.0006
673 MUSCULOSKELETAL STIFFNESS 52 0.0006
674 SINUS CONGESTION 8 0.0006
675 NAUSEA 468 0.0006
676 HIP FRACTURE 19 0.0006
677 VERTIGO 36 0.0006
678 FLUSHING 60 0.0006
679 DRUG INEFFECTIVE 775 0.0006
680 PNEUMONITIS 16 0.0006
681 CONSTIPATION 128 0.0006
682 IMPAIRED GASTRIC EMPTYING 8 0.0006
683 MACULAR DEGENERATION 7 0.0006
684 MOBILITY DECREASED 42 0.0006
685 ASTHMA 66 0.0006
686 INFLAMMATION 30 0.0006
687 HYPERTENSION 123 0.0006
688 RESPIRATORY ARREST 16 0.0006
689 DELUSION 9 0.0006
690 LOCALISED INFECTION 14 0.0006
691 DIABETES MELLITUS 44 0.0006
692 BURSITIS 7 0.0006
693 THERAPY PARTIAL RESPONDER 9 0.0006
694 RESPIRATORY TRACT INFECTION 15 0.0006
695 PRESYNCOPE 14 0.0006
696 INCREASED APPETITE 11 0.0006
697 FEELING COLD 16 0.0006
698 ABDOMINAL PAIN UPPER 118 0.0006
699 MUCOSAL INFLAMMATION 15 0.0006
700 SEROTONIN SYNDROME 11 0.0006
701 ABDOMINAL DISCOMFORT 96 0.0006
702 WITHDRAWAL SYNDROME 24 0.0006
703 PAIN 351 0.0006
704 HALLUCINATION 43 0.0006
705 MOUTH ULCERATION 12 0.0006
706 DRY SKIN 76 0.0006
707 DYSPEPSIA 56 0.0006
708 DYSPNOEA 322 0.0006
709 WEIGHT INCREASED 127 0.0006
710 DRY MOUTH 46 0.0006
711 EYE PRURITUS 19 0.0006
712 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
713 FALL 188 0.0006
714 EATING DISORDER 12 0.0006
715 PLATELET COUNT DECREASED 60 0.0006
716 JOINT INJURY 12 0.0006
717 THIRST 10 0.0006
718 INFECTION 81 0.0006
719 RED BLOOD CELL COUNT DECREASED 16 0.0006
720 PNEUMONIA 181 0.0006
721 ANGINA PECTORIS 16 0.0006
722 BLOOD GLUCOSE INCREASED 105 0.0006
723 COGNITIVE DISORDER 26 0.0006
724 VISION BLURRED 76 0.0006
725 TOOTHACHE 10 0.0006
726 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
727 APATHY 8 0.0005
728 RASH 239 0.0005
729 MYDRIASIS 7 0.0005
730 PHOTOSENSITIVITY REACTION 9 0.0005
731 SWELLING 51 0.0005
732 SKIN ULCER 14 0.0005
733 COVID-19 95 0.0005
734 VISUAL IMPAIRMENT 67 0.0005
735 SKIN HAEMORRHAGE 8 0.0005
736 SKIN DISORDER 18 0.0005
737 URTICARIA 90 0.0005
738 COLON CANCER 8 0.0005
739 BACTERIAL INFECTION 10 0.0005
740 AGITATION 39 0.0005
741 DEPRESSION 120 0.0005
742 THERAPY CESSATION 27 0.0005
743 HAEMATOCHEZIA 29 0.0005
744 ABORTION SPONTANEOUS 21 0.0005
745 SKIN DISCOLOURATION 24 0.0005
746 C-REACTIVE PROTEIN INCREASED 19 0.0005
747 DISTURBANCE IN ATTENTION 28 0.0005
748 RESTLESSNESS 19 0.0005
749 EMOTIONAL DISORDER 16 0.0005
750 FREQUENT BOWEL MOVEMENTS 14 0.0005
751 INTENTIONAL OVERDOSE 33 0.0005
752 CEREBROVASCULAR ACCIDENT 87 0.0005
753 POOR QUALITY SLEEP 11 0.0005
754 SKIN LESION 14 0.0005
755 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
756 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
757 HEAD INJURY 16 0.0005
758 DYSARTHRIA 19 0.0005
759 HYPOMAGNESAEMIA 7 0.0005
760 RASH GENERALISED 13 0.0005
761 COORDINATION ABNORMAL 7 0.0005
762 ABSCESS 8 0.0005
763 RESPIRATORY DISORDER 15 0.0005
764 MYELOSUPPRESSION 18 0.0005
765 PREGNANCY 10 0.0005
766 SPINAL FRACTURE 10 0.0005
767 MOVEMENT DISORDER 16 0.0005
768 OXYGEN SATURATION DECREASED 28 0.0005
769 OEDEMA 27 0.0005
770 INTERSTITIAL LUNG DISEASE 24 0.0005
771 MUSCLE TIGHTNESS 8 0.0005
772 FEEDING DISORDER 10 0.0005
773 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
774 SNEEZING 11 0.0005
775 SYNCOPE 49 0.0005
776 EAR INFECTION 13 0.0005
777 CATARACT 29 0.0005
778 MULTIPLE FRACTURES 8 0.0005
779 MIDDLE INSOMNIA 9 0.0005
780 GASTROINTESTINAL DISORDER 43 0.0005
781 DEHYDRATION 64 0.0005
782 INTENTIONAL PRODUCT MISUSE 42 0.0005
783 GASTROENTERITIS 7 0.0005
784 PAIN IN EXTREMITY 141 0.0005
785 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
786 HOT FLUSH 36 0.0005
787 MUSCLE TWITCHING 11 0.0005
788 MUSCULOSKELETAL PAIN 25 0.0005
789 CELLULITIS 24 0.0005
790 FEELING ABNORMAL 114 0.0005
791 FACE OEDEMA 8 0.0005
792 VOMITING 223 0.0005
793 HAEMATEMESIS 12 0.0005
794 NASOPHARYNGITIS 87 0.0005
795 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
796 CYSTITIS 15 0.0005
797 DIVERTICULITIS 13 0.0005
798 RETCHING 10 0.0005
799 HAEMORRHAGE INTRACRANIAL 7 0.0005
800 IMPAIRED WORK ABILITY 10 0.0005
801 HYPOAESTHESIA 70 0.0005
802 GLAUCOMA 9 0.0005
803 DRUG INTOLERANCE 45 0.0005
804 ERUCTATION 9 0.0005
805 MUSCULOSKELETAL DISCOMFORT 8 0.0005
806 DEEP VEIN THROMBOSIS 30 0.0005
807 MENTAL DISORDER 20 0.0005
808 SPEECH DISORDER 24 0.0005
809 DIABETIC KETOACIDOSIS 11 0.0005
810 CONFUSIONAL STATE 74 0.0005
811 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
812 ROAD TRAFFIC ACCIDENT 19 0.0005
813 PANCREATITIS 24 0.0005
814 HYPERSOMNIA 13 0.0005
815 LYMPHOMA 7 0.0005
816 LOSS OF CONSCIOUSNESS 58 0.0005
817 MULTIPLE SCLEROSIS RELAPSE 31 0.0005
818 UPPER LIMB FRACTURE 9 0.0005
819 VIRAL INFECTION 15 0.0005
820 CEREBRAL INFARCTION 11 0.0004
821 ISCHAEMIC STROKE 8 0.0004
822 THROMBOSIS 36 0.0004
823 HYPERSENSITIVITY 83 0.0004
824 SOMNOLENCE 90 0.0004
825 FULL BLOOD COUNT DECREASED 9 0.0004
826 EXTRA DOSE ADMINISTERED 18 0.0004
827 LEUKOCYTOSIS 8 0.0004
828 LABORATORY TEST ABNORMAL 13 0.0004
829 MALAISE 193 0.0004
830 PRODUCT AVAILABILITY ISSUE 10 0.0004
831 PRODUCT DOSE OMISSION ISSUE 129 0.0004
832 VAGINAL HAEMORRHAGE 19 0.0004
833 RHINORRHOEA 28 0.0004
834 HYPOPHAGIA 11 0.0004
835 WOUND 12 0.0004
836 THERAPEUTIC RESPONSE DECREASED 26 0.0004
837 SLEEP DISORDER 30 0.0004
838 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
839 TREATMENT FAILURE 35 0.0004
840 MEMORY IMPAIRMENT 58 0.0004
841 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 76 0.0004
842 SEDATION 11 0.0004
843 RECTAL HAEMORRHAGE 18 0.0004
844 DYSGEUSIA 31 0.0004
845 PULMONARY FIBROSIS 8 0.0004
846 LOWER LIMB FRACTURE 8 0.0004
847 DRUG PRESCRIBING ERROR 8 0.0004
848 ANAPHYLACTIC REACTION 23 0.0004
849 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
850 LUNG NEOPLASM MALIGNANT 17 0.0004
851 PRESCRIBED OVERDOSE 8 0.0004
852 SUICIDE ATTEMPT 25 0.0004
853 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
854 NEUROPATHY PERIPHERAL 39 0.0004
855 TOXICITY TO VARIOUS AGENTS 69 0.0004
856 FEAR 11 0.0004
857 PAIN OF SKIN 11 0.0004
858 LUNG DISORDER 20 0.0004
859 KIDNEY INFECTION 8 0.0004
860 PSYCHOTIC DISORDER 12 0.0004
861 ABNORMAL BEHAVIOUR 16 0.0004
862 DISORIENTATION 16 0.0004
863 MOOD ALTERED 11 0.0004
864 BLOOD PRESSURE ABNORMAL 8 0.0004
865 ORAL PAIN 9 0.0004
866 DEVICE DELIVERY SYSTEM ISSUE 11 0.0004
867 RASH PAPULAR 9 0.0004
868 ECZEMA 21 0.0004
869 DEVICE USE ISSUE 7 0.0004
870 PULMONARY EMBOLISM 38 0.0004
871 CYTOKINE RELEASE SYNDROME 8 0.0004
872 INTESTINAL OBSTRUCTION 15 0.0004
873 COLD SWEAT 7 0.0004
874 COLITIS 15 0.0004
875 CARDIAC DISORDER 37 0.0004
876 BONE PAIN 23 0.0004
877 VISUAL ACUITY REDUCED 13 0.0004
878 INJECTION SITE RASH 12 0.0004
879 LIP SWELLING 13 0.0004
880 SEIZURE 45 0.0004
881 BLOOD CHOLESTEROL INCREASED 18 0.0004
882 INTENTIONAL DOSE OMISSION 11 0.0004
883 UNEVALUABLE EVENT 29 0.0004
884 PRODUCT DOSE OMISSION 25 0.0004
885 DERMATITIS 8 0.0004
886 SKIN EXFOLIATION 32 0.0004
887 NEEDLE ISSUE 11 0.0004
888 MEDICATION ERROR 21 0.0004
889 SURGERY 22 0.0004
890 JOINT SWELLING 45 0.0004
891 DISEASE PROGRESSION 44 0.0004
892 NEPHROLITHIASIS 17 0.0004
893 PSORIATIC ARTHROPATHY 15 0.0004
894 MUSCULOSKELETAL DISORDER 7 0.0004
895 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
896 STOMATITIS 22 0.0004
897 ABNORMAL DREAMS 10 0.0004
898 URINARY RETENTION 12 0.0004
899 CRYING 13 0.0004
900 PANIC ATTACK 13 0.0004
901 AMNESIA 23 0.0004
902 RASH PRURITIC 19 0.0004
903 PRODUCT QUALITY ISSUE 47 0.0003
904 ERYTHEMA 71 0.0003
905 JOINT STIFFNESS 9 0.0003
906 COMA 16 0.0003
907 BLOOD GLUCOSE DECREASED 16 0.0003
908 EXPIRED PRODUCT ADMINISTERED 11 0.0003
909 PALLOR 9 0.0003
910 INJECTION SITE ERYTHEMA 41 0.0003
911 CORONARY ARTERY DISEASE 10 0.0003
912 INJECTION SITE URTICARIA 8 0.0003
913 ANGER 11 0.0003
914 PROCEDURAL PAIN 9 0.0003
915 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
916 ADVERSE DRUG REACTION 29 0.0003
917 DEVICE LEAKAGE 14 0.0003
918 DEVICE DISLOCATION 14 0.0003
919 DEPRESSED MOOD 17 0.0003
920 INCORRECT DOSE ADMINISTERED 73 0.0003
921 BLINDNESS 13 0.0003
922 NIGHTMARE 11 0.0003
923 IRRITABILITY 19 0.0003
924 HAEMORRHAGE 33 0.0003
925 RASH MACULAR 11 0.0003
926 COLITIS ULCERATIVE 14 0.0003
927 ERECTILE DYSFUNCTION 8 0.0003
928 EXPOSURE VIA SKIN CONTACT 8 0.0003
929 APPLICATION SITE PRURITUS 7 0.0003
930 IMPAIRED HEALING 10 0.0003
931 DEVICE ISSUE 27 0.0003
932 ACCIDENTAL OVERDOSE 11 0.0003
933 INJECTION SITE PRURITUS 20 0.0003
934 DRUG DOSE OMISSION 49 0.0003
935 SUICIDAL IDEATION 27 0.0003
936 GASTRIC DISORDER 10 0.0003
937 FIBROMYALGIA 7 0.0003
938 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
939 MOOD SWINGS 9 0.0003
940 LACTIC ACIDOSIS 9 0.0003
941 RHEUMATOID ARTHRITIS 31 0.0003
942 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
943 DEVICE BREAKAGE 11 0.0003
944 HAEMATOMA 7 0.0003
945 ILL-DEFINED DISORDER 16 0.0003
946 INJECTION SITE BRUISING 21 0.0003
947 DRUG ADMINISTRATION ERROR 8 0.0003
948 HOSPITALISATION 40 0.0003
949 PSORIASIS 34 0.0003
950 INFUSION RELATED REACTION 17 0.0003
951 NERVOUS SYSTEM DISORDER 8 0.0003
952 BONE DENSITY DECREASED 8 0.0003
953 NEOPLASM MALIGNANT 17 0.0003
954 MALIGNANT NEOPLASM PROGRESSION 26 0.0003
955 ARTHROPATHY 14 0.0003
956 SKIN BURNING SENSATION 18 0.0003
957 MULTIPLE SCLEROSIS 12 0.0003
958 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
959 OSTEONECROSIS 8 0.0002
960 COMPLETED SUICIDE 20 0.0002
961 ADVERSE EVENT 22 0.0002
962 DEATH 204 0.0002
963 RENAL DISORDER 11 0.0002
964 PLASMA CELL MYELOMA 9 0.0002
965 FEMUR FRACTURE 7 0.0002
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
967 SKIN IRRITATION 10 0.0002
968 INJECTION SITE MASS 8 0.0002
969 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
970 INJECTION SITE PAIN 65 0.0002
971 CONVULSION 12 0.0002
972 DERMATITIS ATOPIC 11 0.0002
973 DEVICE MALFUNCTION 14 0.0002
974 NO ADVERSE EVENT 36 0.0002
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
976 MYOCARDIAL INFARCTION 34 0.0002
977 OVERDOSE 42 0.0002
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
979 UNDERDOSE 14 0.0002
980 DRUG DOSE OMISSION BY DEVICE 14 0.0002
981 INJECTION SITE SWELLING 13 0.0002
982 INJECTION SITE HAEMORRHAGE 13 0.0002
983 PRODUCT STORAGE ERROR 14 0.0002
984 AGGRESSION 8 0.0002
985 DRUG WITHDRAWAL SYNDROME 14 0.0002
986 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
987 BREAST CANCER 14 0.0002
988 INJECTION SITE REACTION 10 0.0001
989 DRUG EFFECT DECREASED 7 0.0001
990 ACNE 9 0.0001
991 PROSTATE CANCER 9 0.0001
992 DRUG DEPENDENCE 8 0.0000